Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Lacroix

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
International Journal of Cancer|October 26, 2007
Persistent use of "false" cell linesMarc Lacroix
Cancer Chemotherapy and Pharmacology|May 27, 2008
MDA-MB-435 cells are from melanoma, not from breast cancerMarc Lacroix
Endocrine-Related Cancer|December 13, 2006
Significance, detection and markers of disseminated breast cancer cellsMarc Lacroix
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 3, 2004
Direct-to-consumer advertisingMarc Lacroix
Breast Cancer Research and Treatment|April 11, 2008
Poor usage of HUGO standard gene nomenclature in breast cancer studiesMarc Lacroix
Breast Cancer Research and Treatment|February 6, 2004
Relevance of breast cancer cell lines as models for breast tumours: an updateMarc Lacroix, Guy Leclercq
Breast Cancer Research and Treatment|March 9, 2005
The "portrait" of hereditary breast cancerMarc Lacroix, Guy Leclercq
Endocrine-Related Cancer|May 27, 2006
p53 and breast cancer, an updateMarc Lacroix, Robert-Alain Toillon, Guy Leclercq
Current Cancer Drug Targets|February 16, 2006
Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cellsGuy Leclercq, Marc Lacroix, Ioanna Laïos, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 14, 2002
Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cellsAna Rivas, Marc Lacroix, Fátima Olea-Serrano, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|October 26, 2007
Persistent use of "false" cell linesMarc Lacroix
Cancer Chemotherapy and Pharmacology|May 27, 2008
MDA-MB-435 cells are from melanoma, not from breast cancerMarc Lacroix
Endocrine-Related Cancer|December 13, 2006
Significance, detection and markers of disseminated breast cancer cellsMarc Lacroix
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 3, 2004
Direct-to-consumer advertisingMarc Lacroix
Breast Cancer Research and Treatment|April 11, 2008
Poor usage of HUGO standard gene nomenclature in breast cancer studiesMarc Lacroix
Breast Cancer Research and Treatment|February 6, 2004
Relevance of breast cancer cell lines as models for breast tumours: an updateMarc Lacroix, Guy Leclercq
Breast Cancer Research and Treatment|March 9, 2005
The "portrait" of hereditary breast cancerMarc Lacroix, Guy Leclercq
Endocrine-Related Cancer|May 27, 2006
p53 and breast cancer, an updateMarc Lacroix, Robert-Alain Toillon, Guy Leclercq
Current Cancer Drug Targets|February 16, 2006
Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cellsGuy Leclercq, Marc Lacroix, Ioanna Laïos, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 14, 2002
Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cellsAna Rivas, Marc Lacroix, Fátima Olea-Serrano, et al.
Pageof 2